HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia (2022)
- Authors:
- USP affiliated authors: GUIMARAES, ELAINE APARECIDA DEL BEL BELLUZ - FORP ; GOMES, FELIPE VILLELA - FMRP ; GUIMARÃES, FRANCISCO SILVEIRA - FMRP ; PEDRAZZI, JOÃO FRANCISCO CORDEIRO - FMRP
- Unidades: FORP; FMRP
- DOI: 10.1016/j.pnpbp.2022.110553
- Subjects: CANABINOIDES; ESQUIZOFRENIA; FARMACOTERAPIA; COMPORTAMENTO
- Keywords: Cannabinoids; HU-910; Psychosis, CB2; Schizophrenia
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2022
- Source:
- Título: Progress in Neuro-Psychopharmacology and Biological Psychiatry
- ISSN: 0278-5846
- Volume/Número/Paginação/Ano: v. 117, art. 110553, p. 1-9, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CORTEZ, Isadora Lopes et al. HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, v. 117, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2022.110553. Acesso em: 09 fev. 2026. -
APA
Cortez, I. L., Silva, N. R., Rodrigues, N. S., Pedrazzi, J. F. C., Del Bel, E. A., Mechoulam, R., et al. (2022). HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 117, 1-9. doi:10.1016/j.pnpbp.2022.110553 -
NLM
Cortez IL, Silva NR, Rodrigues NS, Pedrazzi JFC, Del Bel EA, Mechoulam R, Gomes FV, Guimarães FS. HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2022 ; 117 1-9.[citado 2026 fev. 09 ] Available from: https://doi.org/10.1016/j.pnpbp.2022.110553 -
Vancouver
Cortez IL, Silva NR, Rodrigues NS, Pedrazzi JFC, Del Bel EA, Mechoulam R, Gomes FV, Guimarães FS. HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2022 ; 117 1-9.[citado 2026 fev. 09 ] Available from: https://doi.org/10.1016/j.pnpbp.2022.110553 - Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission
- Medicamentos antipsicóticos
- What can we learn from animal models to study schizophrenia?
- Effects of doxycycline in swiss mice predictive models of schizophrenia
- The role of nitric oxide in salivary gland hypertrophy induced by isoproterenol
- Inhibition of nitric oxide synthase increases synaptophysin mRNA expression in the hippocampal formation of rats
- Efeito de antagonistas serotonérgicos na catalepsia induzida por L-noarg em camundongos
- Different role of isoproterenol and NOS inhibitors on salivary ducts of rats
- Social isolation increases 5HT1a mRNA expression in the hipocampal formation of rats
- Locomotor effects of acute and chronic inhibition of nitric oxide synthesis in mice
Informações sobre o DOI: 10.1016/j.pnpbp.2022.110553 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003153995.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
